Outlook Therapeutics shares owned by Gables Capital Management
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Gables Capital Management
from 13F filings
Historical chart of Gables Capital Management investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Gables Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Gables Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $58k | 147k | 0.39 |
| 2023-09-30 | $34k | 155k | 0.22 |
| 2023-06-30 | $116k | 67k | 1.74 |
| 2023-03-31 | $73k | 67k | 1.09 |
| 2022-12-31 | $72k | 67k | 1.08 |
| 2022-09-30 | $75k | 62k | 1.22 |
| 2022-06-30 | $63k | 62k | 1.02 |
| 2022-03-31 | $83k | 47k | 1.78 |
| 2021-12-31 | $5.0k | 3.5k | 1.43 |
More positions owned by Gables Capital Management
Home Depot (HD)
View all positions for Gables Capital Management